Skip to main content
. 2004 Jul 10;54(2):172–178. doi: 10.1007/s00262-004-0575-z

Table 1.

Frequencies (%) of KIR genes in the Bulgarian population

  Melanoma patients (n=50) Control group (n=54)
Inhibitory KIR
 2DL1 90.0 90.7
 2DL2 54.0 50.0
 2DL3 90.0 90.7
 3DL1 90.0 90.7
 3DL2 100 100
Activating KIR 
 2DS1 38.0 37.0
 2DS2 56.0 53.7
 2DS3 32.0 27.8
 2DS4 94.0 96.3
 3DS1 34.0 38.9
KIR genotype 
 AA 50.0 50.0
 AB 42.0 40.7
 BB 8.0 9.3